1. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway
   Junshan Liu et al, 2016, Cellular Oncology CrossRef
2. Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells
   Xin Xu et al, 2018, Cancer Science CrossRef
3. Anti-oxidative effects of catechins and theaflavins on glutamate-induced HT22 cell damage
   Jinting He et al, 2019, RSC Advances CrossRef
4. Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment
   Henry McCann et al, 2018, Cancers CrossRef
5. Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts
   Sonia Liggi et al, 2014, Future Medicinal Chemistry CrossRef
6. Identification of dehydroxy isoquine and isotebuquine as promising anticancer agents targeting K+ channel
   Angel H. Romero et al, 2019, Chemical Biology & Drug Design CrossRef
7. Lysosomes and Cancer Progression: A Malignant Liaison
   Eda R. Machado et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
8. In vivo hyperoxia induces hypoxia-inducible factor-1α overexpression in LNCaP tumors without affecting the tumor growth rate
   Laura Terraneo et al, 2014, The International Journal of Biochemistry & Cell Biology CrossRef
9. Mefloquine, an anti‐malaria agent, causes reactive oxygen species‐dependent cell death in mast cells via a secretory granule‐mediated pathway
   Aida Paivandy et al, 2014, Pharmacology Research & Perspectives CrossRef
10. Cellular targets of mefloquine
    Debasish Kumar Ghosh et al, 2021, Toxicology CrossRef
11. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
    Faiqa Mudassar et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
12. Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia
    Hui Lam Yi et al, 2019, Translational Oncology CrossRef
13. Further study of oxazolidines derived from mefloquine and arenealdehydes: diastereoisomers and polymorphs
    Raoni S.B. Goncalves et al, 2016, Zeitschrift für Kristallographie - Crystalline Materials CrossRef
14. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
    Jianzhang Wu et al, 2017, European Journal of Medicinal Chemistry CrossRef
15. Melatonin and Docosahexaenoic Acid Decrease Proliferation of PNT1A Prostate Benign Cells via Modulation of Mitochondrial Bioenergetics and ROS Production
    Guilherme H. Tamarindo et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
16. Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function
    Bing Wan et al, 2021, Biochemical and Biophysical Research Communications CrossRef
17. Anti-malarials are anti-cancers and vice versa – One arrow two sparrows
    Chanakya Nath Kundu et al, 2015, Acta Tropica CrossRef
18. Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
    Yifei Xie et al, 2020, Frontiers in Oncology CrossRef
19. Understanding the Role of Autophagy in Cancer Formation and Progression Is a Real Opportunity to Treat and Cure Human Cancers
    Simone Patergnani et al, 2021, Cancers CrossRef
20. Oxidative stress mediated apoptotic potential of mefloquine on experimental trichinellosis
    Dalia A. Elmehy et al, 2021, Acta Tropica CrossRef
21. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors
    Qian Tao et al, 2024, Journal for ImmunoTherapy of Cancer CrossRef
22. Valosin‑containing protein promotes metastasis of osteosarcoma through autophagy induction and anoikis inhibition via the ERK/NF‑κβ/beclin‑1 signaling pathway
    Xin Long et al, 2019, Oncology Letters CrossRef